Abstract:Abstract Background: Angiogenesis is essential for the growth and metastasis of solid tumors, including breast cancer. Although the zinc finger-homeodomain transcription factor ZEB1 is implied as a key regulatory factor in multistep carcinogenesis of breast cancer, its direct role in the regulation of tumor angiogenesis has not been well elucidated. In this report, we extended our study to examine the potential effect of ZEB1 in breast cancer angiogenesis and its molecular mechanism using the in vitro and in vivo models. Materials and Methods: Quantitative RT-PCR, immunoblotting, and ELISA were used to detect ZEB1-induced expression and/or secretion of VEGF in the absence or presence of the indicated signaling pathway inhibitors (the PI3K, NF-κB, and MAPKs pathways) in MDA-MB-231 breast cancer cells. Tube formation assay was performed to detect ZEB1-driven angiogenesis using human umbilical vein endothelial cells (HUVEC). Luciferase and CHIP assays were used to determine the transcriptional activity of the wild-type and mutant VEGF promoters affected by ZEB1. A nude mouse tumor xenograft model was used to examine ZEB1-driven angiogenesis in vivo. The relationship between the expression of ZEB1 and VEGF protein in human breast cancer specimens was assessed by immunohistochemistry. Results: We found that ectopic expression of ZEB1 promotes the expression of VEGF at both the mRNA and the protein levels in MDA-MB-231 cells, which effect is specifically mediated through the p38 and PI3K pathways. The conditioned medium derived from ZEB1-overexpressing MDA-MB-231 cells significantly induces the tube formation of HUVEC compared with that from control-overexpressing cells. Importantly, elevated expression of ZEB1 resulted in an increased angiogenesis in a nude mouse tumor xenograft model. We further moved on to detect whether ZEB1 is a bona-fide transcriptional regulator of VEGF. The results of luciferase and CHIP assays showed that ZEB1 transcriptionally induces the promoter activity of human VEGF by recruiting Sp1 to its biding sites on the VEGF promoter, thus up-regulating VEGF expression in MDA-MB-231 cells. Through the study of breast cancer specimens, we found a strong positive correlation between ZEB1 and VEGF protein expression, further supporting the contribution of ZEB1/VEGF cascade to tumor angiogenesis in breast cancer. Conclusions: Our data demonstrated that ZEB1 up-regulates VEGF expression and thus induces tumor angiogenesis in breast cancer. Thus, inhibition of VEGF expression by down-regulating ZEB1 provides a potential new strategy for overcoming tumor angiogenesis. Citation Format: Qi Tong, Lingjia Liu, Lin Liang, Yang Gao, Shuang Yang. Elevated expression of ZEB1 upregulates VEGF expression and induces tumor angiogenesis in breast cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1599. doi:10.1158/1538-7445.AM2014-1599

ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer

Abstract 1599: Elevated Expression of ZEB1 Upregulates VEGF Expression and Induces Tumor Angiogenesis in Breast Cancer

Jagged1-Notch1-deployed Tumor Perivascular Niche Promotes Breast Cancer Stem Cell Phenotype Through Zeb1.

Oncogenic Functions of the EMT-related Transcription Factor ZEB1 in Breast Cancer

ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3.

HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer

Increased Expression of CYP4Z1 Promotes Tumor Angiogenesis and Growth in Human Breast Cancer.

ZEB1 Induces ROS Generation Through Directly Promoting MCT4 Transcription to Facilitate Breast Cancer.

ZEB1 Confers Chemotherapeutic Resistance to Breast Cancer by Activating ATM

The Zeb1-Cxcl1 Axis Impairs the Antitumor Immune Response by Inducing M2 Macrophage Polarization in Breast Cancer

ZEB1-Mediated Transcriptional Upregulation of circWWC3 Promotes Breast Cancer Progression through Activating Ras Signaling Pathway.

ZEB1 Promotes Invasion and Metastasis of Endometrial Cancer by Interacting with HDGF and Inducing Its Transcription.

Vascular Endothelial Growth Factor Receptor-1 Activation Promotes Migration And Invasion Of Breast Cancer Cells Through Epithelial-Mesenchymal Transition

Hypoxia-induced Factor-1 Alpha Upregulates Vascular Endothelial Growth Factor C to Promote Lymphangiogenesis and Angiogenesis in Breast Cancer Patients

ZKSCAN5 Activates VEGFC Expression by Recruiting SETD7 to Promote the Lymphangiogenesis, Tumour Growth, and Metastasis of Breast Cancer

NOTCH3 Inhibits Transcription Factor ZEB1 Expression and Metastasis of Breast Cancer Cells Via Transcriptionally Upregulating Mir-223.

Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer

Inactivation of Endothelial ZEB1 Impedes Tumor Progression and Sensitizes Tumors to Conventional Therapies.

ZEB1‐mediated Vasculogenic Mimicry Formation Associates with Epithelial–mesenchymal Transition and Cancer Stem Cell Phenotypes in Prostate Cancer

Breast Cancer Cells-Derived Von Willebrand Factor Promotes VEGF-A-related Angiogenesis Through PI3K/Akt-miR-205-5p Signaling Pathway

Pseudogene CYP4Z2P 3'UTR Promotes Angiogenesis in Breast Cancer.